I want to walk through a recent review that gets fairly technical, but does something I think is genuinely valuable: it identifies a single molecule that helps explain why metabolic dysfunction reaches into reproductive health in the specific ways I described more generally in an earlier post on this site. Reviewing a review is a slightly unusual thing to do, but I think it fits the educational mission of this site well — sometimes the most useful thing I can do is translate a technical synthesis into something a patient can actually use.
What CD36 actually is
CD36 is a protein found on the surface of several different cell types — fat cells, muscle cells, and immune cells called macrophages — where it does two distinct jobs simultaneously. First, it's a fatty acid transporter: it's the same protein I described in the exercise metabolism post as the mechanism muscle uses to pull fatty acids in for fuel during exercise. Second, and less widely known, it's an immune receptor — it helps immune cells detect and respond to certain lipid-based danger signals, working alongside other well-known immune sensors called Toll-like receptors.
This dual identity — fat transporter and immune sensor, built into the same molecule — is the reason CD36 shows up as a genuine bridge between metabolism and inflammation, rather than sitting cleanly in one category or the other.
The insulin resistance connection
Here's a detail from the review I found genuinely clarifying. In healthy metabolism, insulin tells muscle and fat cells to pull in both glucose (through a transporter called GLUT4) and fatty acids (through CD36) in a coordinated way. In insulin-resistant states — the same insulin resistance I've described as central to metabolic syndrome — this coordination breaks down. Glucose uptake through GLUT4 gets blunted, the way you'd expect with insulin resistance. But CD36-driven fat uptake often doesn't slow down along with it — in some cases it stays elevated or even increases, particularly when there's excess fat available in the bloodstream. That mismatch means fat keeps piling into tissue even as the tissue's ability to handle sugar is failing, which the review connects directly to worsening insulin resistance and contractile dysfunction in muscle. It's a specific molecular explanation for a pattern I've described more generally throughout this site: metabolic dysfunction tends to reinforce itself.
The inflammation side, including a genuine two-way switch
CD36 also plays directly into the inflammation story I've covered in earlier posts on this site. When CD36 encounters certain lipid signals — including oxidized cholesterol particles, the kind associated with cardiovascular risk — it partners with Toll-like receptors to activate NF-κB, the master switch driving inflammatory gene expression I've referenced before. It also feeds into a separate inflammatory pathway called the NLRP3 inflammasome, which produces some of the same inflammatory signaling molecules involved in chronic low-grade inflammation more broadly.
What I want to be fair about, though, is that CD36 isn't simply "bad." The review describes a genuine molecular seesaw: CD36 can also activate a different pathway, through a receptor called PPARγ, that pushes immune cells toward an anti-inflammatory, tissue-supportive state instead. Which direction wins out — inflammatory or anti-inflammatory — depends heavily on context: what's happening metabolically in that specific tissue at that specific moment. This is consistent with something I've said before about inflammation generally: it's a regulatory system capable of both harm and genuine benefit, not simply a switch that should always be turned off.
Where this gets genuinely new: reproduction
This is the part of the review that connects most directly to the reproductive comorbidities I described in an earlier post on metabolic syndrome's full reach — irregular cycles, infertility, and miscarriage risk. That post described these connections at the level of "metabolic dysfunction affects this too." This review gets much more specific about a plausible mechanism.
In the ovary, CD36 appears to help regulate which egg-containing follicles survive and which are naturally eliminated, and it's involved in how developing eggs manage their own lipid stores — genuinely important for egg quality. There's even evidence CD36 on the egg's surface plays a direct role in recognizing sperm during fertilization itself; blocking it experimentally reduces fertilization success.
In the uterus, CD36 activity rises specifically during the window when the uterine lining becomes receptive to an embryo, suggesting a role in making that lining genuinely ready for implantation.
In pregnancy, the connections become the most clinically concrete. In gestational diabetes, elevated CD36 in the placenta drives excess fat uptake and the same inflammatory cascade described above, occurring locally in placental tissue. In preeclampsia — a serious pregnancy complication involving high blood pressure — CD36 activation in blood vessel lining appears to contribute to vessel dysfunction and impaired blood vessel growth, both central features of that condition. And in recurrent miscarriage, the pattern actually reverses: the review describes lower CD36 activity (specifically, reduced CD36 paired with reduced PPARγ) in immune cells at the site of pregnancy loss, correlating with a more inflammatory local environment. That's worth sitting with — this isn't a simple "more CD36 is always worse" story. Context and tissue matter enormously.
One detail I think is worth including directly: the review notes that blood immune cells from obese pregnant women show measurably higher CD36 and Toll-like receptor levels, alongside more inflammatory activation, compared to lean pregnant women. That's a real, human, tissue-level observation — not just an animal finding — connecting maternal obesity to this exact pathway.
How much confidence this evidence actually deserves
I want to be precise about what kind of source this is. This is a review article — the authors themselves describe it as synthesizing existing mechanistic, animal, and clinical evidence, not reporting a new study of their own. Much of the most detailed mechanistic work — how CD36 gets trafficked to the cell surface, exactly which enzymes modify it — comes from cell and animal research. The reproductive-disease connections draw on a mix of animal models and real human tissue samples (placentas from pregnancies with gestational diabetes, preeclampsia, and recurrent miscarriage), which is a genuinely stronger evidence base than pure animal work, but still largely observational and correlational rather than the kind of interventional human trial data I hold to the highest standard elsewhere on this site. The authors themselves are honest that the mechanisms remain "under investigation" and call for more human-focused research using newer tools.
What I'd want you to take from this
I think the real value of a paper like this isn't a specific action item — it's the way it reinforces, at a genuine molecular level, something I've argued throughout this site: that fat, inflammation, and seemingly unrelated aspects of health are tied together by literal shared machinery, not just loose statistical association. CD36 is one molecule doing double duty as a fat transporter and an immune sensor, showing up in muscle, in fat tissue, and — this review makes clear — in the ovary, the uterus, and the placenta. If you're dealing with unexplained fertility difficulty, recurrent pregnancy loss, or a diagnosis like gestational diabetes or preeclampsia, this is exactly the kind of connection worth raising with your provider — not because CD36 itself is something we can currently target directly, but because it's one more reason metabolic health and reproductive health deserve to be treated as connected, not separate, conversations.
Curious how your own metabolic health might be connected to a reproductive concern?
No spam. Occasional new posts and updates from The Center for Metabolic Health.
Medical disclaimer: This content is provided for general educational and informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any condition, and it does not create a physician-patient relationship. Every patient's medical history, health status, and treatment needs are different. Always consult your own physician or qualified healthcare provider before starting, stopping, or changing any medication or treatment, and before making any decisions based on information found here. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room.